MeiraGTx Holdings (MGTX) EBITDA Margin Growth (1y) (2020 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 3,609.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1,536.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -957.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 8,807.00 |
| 10 | MeiraGTx Holdings | 856.58 Mn | 790.65 Mn | 74.89 Mn | 21,050.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 21,050.00 |
| Sep 30, 2025 | -1.17 Mn |
| Jun 30, 2025 | 1.63 Mn |
| Dec 31, 2024 | -74,852.00 |
| Sep 30, 2024 | 37,854.00 |
| Jun 30, 2024 | -1.65 Mn |
| Mar 31, 2024 | -219,415.00 |
| Dec 31, 2023 | -12,360.00 |
| Sep 30, 2023 | -15,832.00 |
| Jun 30, 2023 | -66,002.00 |
| Mar 31, 2023 | -46,448.00 |
| Dec 31, 2022 | 73,920.00 |
| Sep 30, 2022 | -25,702.00 |
| Jun 30, 2022 | 15,318.00 |
| Mar 31, 2022 | 304.00 |
| Dec 31, 2021 | 32,112.00 |
| Sep 30, 2021 | -12,776.00 |
| Jun 30, 2021 | 60,590.00 |
| Mar 31, 2021 | -24,113.00 |
| Dec 31, 2020 | -22,785.00 |
| Sep 30, 2020 | 3,859.00 |
| Jun 30, 2020 | -3,544.00 |
| Mar 31, 2020 | 215,649.00 |